✦ LIBER ✦

Interferon alfa and vinblastine versus medroxyprogesterone acetate in the treatment of metastatic renal cell carcinoma

✍ Scribed by M. Kriegmair; R. Oberneder; A. Hofstetter

Book ID: 119487763
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 497 KB
Volume: 45
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(99)80079-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon-alpha and vinblastine versus

Interferon-alpha and vinblastine versus medroxy-progesteronacetat in the treatment of metastatic renal cell carcinoma

✍ M. Kriegmair; R. Oberneder; A. Hofstetter 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 123 KB

Recombinant interferon alfa-2a with or w

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma

✍ Sophie D. Fossåu; Stephen T. De Garis; Mona S. Heier; Asbjøsrn Flokkmann; Hans H 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Combination therapy of low dose alfa-int

Combination therapy of low dose alfa-interferon and medroxyprogesterone acetate in metastatic renal cell cancer. A randomized multicenter trial

✍ F. Porzsolt; D. Messerer; R. Hautmann; A. Gottwald; H. Sparwasser; K. Stockamp; 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Further experience with recombinant inte

Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: A progress report

✍ S. D. Fosså; S. T. De Garis 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 404 KB

Thirty-three patients with measurable metastatic renal cell carcinoma were entered into 2 consecutive phase II protocols using interferon alfa-2a. In protocol I, 20 patients were treated with interferon alfa-2a at a dose of 36 x I06 IU i.m. t.i.w. Vinblastine was also given t o 18 of these patients

PIN26 ECONOMIC EVALUATION OF SUNITINIBVS

PIN26 ECONOMIC EVALUATION OF SUNITINIBVS. INTERFERON-ALFA (IFN-ALFA) IN FIRST-LINE TREATMENT OF METASTATIC RENAL CELL CARCINOMA (MRCC) IN COLOMBIA

✍ JI Godoy; AF Cardona; N Alvis; CH Arango; M Romero; A Spath; P Ramirez; HA Cacer 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

Randomized Phase III Trial of Temsirolim

Randomized Phase III Trial of Temsirolimus and Bevacizumab Versus Interferon Alfa and Bevacizumab in Metastatic Renal Cell Carcinoma: INTORACT Trial

✍ Rini, B. I.; Bellmunt, J.; Clancy, J.; Wang, K.; Niethammer, A. G.; Hariharan, S 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 266 KB